[DOI] [PMC free article] [PubMed] [Google Scholar] 96.Criswell DS, Booth FW, DeMayo F, Schwartz RJ, Gordon SE, Fiorotto ML
Roughly 10% of the population carries these variants, which appear to cause a mysterious form of "GLP-1 resistance." In several clinical trials, carriers were significantly less likely to reach healthy blood sugar targets while taking GLP-1 medications
PMID: 28140328
Our CLP model showed chronic Nrf2/HO-1/GPX4 suppression (day 7) linked to GSH depletion, ferroptosis, and irreversible antioxidant collapse (Xie et al., 2020), supporting Nrf2 activators (e.g., sulforaphane) or GSH precursors (e.g., NAC) as interventions (Yusri et al., 2025)
If a person believes they may have a B12 deficiency, it is important to speak with a doctor as soon as possible
Two independent experimental batches were used, and batch was included in all models as a fixed effect along with its interactions with treatment and age